Results 1 to 10 of about 8,115 (174)

Feasibility Study on Applying Radiophotoluminescent Glass Dosimeters for CyberKnife SRS Dose Verification. [PDF]

PLoS ONE, 2017
CyberKnife is one of multiple modalities for stereotactic radiosurgery (SRS). Due to the nature of CyberKnife and the characteristics of SRS, dose evaluation of the CyberKnife procedure is critical.
Shih-Ming Hsu, Chao-Hsiung Hung, Yi-Jen Liao, Hsiao-Mei Fu, Jo-Ting Tsai, Yung-Hui Huang, David Y C Huang   +6 more
doaj   +2 more sources

CyberKnife for Recurrent Malignant Gliomas: A Systematic Review and Meta-Analysis [PDF]

Frontiers in Oncology, 2021
Background and ObjectivePossible treatment strategies for recurrent malignant gliomas include surgery, chemotherapy, radiotherapy, and combined treatments. Among different reirradiation modalities, the CyberKnife System has shown promising results.
Lucio De Maria, Lodovico Terzi di Bergamo, Alfredo Conti, Kazuhiko Hayashi, Valentina Pinzi, Taro Murai, Rachelle Lanciano, Sigita Burneikiene, Michela Buglione di Monale, Stefano Maria Magrini, Marco Maria Fontanella   +10 more
doaj   +2 more sources

A glimpse into the CyberKnife robotic radiosurgery system: technical specifications and developments during thirty years [PDF]

Frontiers in Oncology
The CyberKnife system is a state-of-the-art technology widely used in the treatment of cancer. It incorporates a 6 MV X-band linear accelerator mounted on a six-degree-of-freedom (6DOF) robotic arm, combined with an image-guidance platform, to deliver ...
Payam Samadi Miandoab, Payam Samadi Miandoab, Yansong Wu, Hui jun Xu, Jun Yang, Jun Yang, Gang Ren, Bo Liu, Chao Wang, Gaolong Zhang, Shouping Xu   +10 more
doaj   +2 more sources

Hypofractionated Stereotactic Radiotherapy with CyberKnife for Large Arteriovenous Malformations and Arteriovenous Malformations Located in Eloquent Areas

Neurologia Medico-Chirurgica, 2022
Literature has yet to establish an appropriate treatment strategy for large arteriovenous malformations (AVMs) and AVMs located in eloquent areas. In this study, the treatment outcomes of hypofractionated stereotactic radiotherapy (HSRT) with CyberKnife (
Ryoko NIWA, Shunsuke ICHI, Ryutaro NOMURA, Kengo SATO   +3 more
doaj   +1 more source

Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience

BMC Cancer, 2021
Background The optimal treatment for recurrent high-grade gliomas (rHGGs) remains uncertain. This study aimed to investigate the efficacy and safety of hypofractionated stereotactic radiosurgery (HSRS) as a first-line salvage treatment for in-field ...
Yun Guan, Ji Xiong, Mingyuan Pan, Wenyin Shi, Jing Li, Huaguang Zhu, Xiu Gong, Chao Li, Guanghai Mei, Xiaoxia Liu, Li Pan, Jiazhong Dai, Yang Wang, Enmin Wang, Xin Wang   +14 more
doaj   +1 more source

Dosimetric quality of HyperArc in boost radiotherapy for single glioblastoma: comparison with CyberKnife and manual VMAT

Radiation Oncology, 2023
Background Stereotactic radiotherapy (SRT) and hypo-fractionated radiotherapy are feasible treatment options for single glioblastoma multiforme when combined with conventional radiotherapy or delivered alone.
Mingyuan Pan, Wenqian Xu, Lei Sun, Chaozhuang Wang, Shengnan Dong, Yun Guan, Jun Yang, Enmin Wang   +7 more
doaj   +1 more source

Image-Guided Robotic Radiosurgery for the Treatment of Same Site Spinal Metastasis Recurrences

Frontiers in Oncology, 2021
BackgroundDue to recent medical advancements, patients suffering from metastatic spinal disease have a prolonged life expectancy than several decades ago, and some will eventually experience relapses.
Felix Ehret, Felix Ehret, Lucas Mose, Markus Kufeld, Christoph Fürweger, Christoph Fürweger, Paul Windisch, Paul Windisch, Alfred Haidenberger, Christian Schichor, Jörg-Christian Tonn, Alexander Muacevic   +11 more
doaj   +1 more source

A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol

BMC Cancer, 2022
Background The most frequently diagnosed primary brain tumor is glioblastoma (GBM). Nearly all patients experience tumor recurrence and up to 90% of which is local recurrence.
Yun Guan, Mingyuan Pan, Jun Yang, Qiuxia Lu, Liangfu Han, Ying Liu, Jing Li, Huaguang Zhu, Xiu Gong, Guanghai Mei, Xiaoxia Liu, Li Pan, Jiazhong Dai, Yang Wang, Enmin Wang, Xin Wang   +15 more
doaj   +1 more source

Stereotactic body radiation therapy for patients with heavily pretreated liver metastases and liver tumors

Frontiers in Oncology, 2012
We present our initial experience with CyberKnife stereotactic body radiation therapy (SBRT) in a heavily pretreated group of patients with liver metastases and primary liver tumors.
Rachelle eLanciano, Rachelle eLanciano, John eLamond, Jun eYang, Jing eFeng, Steven eArrigo, Michael eGood, Luther eBrady   +7 more
doaj   +1 more source

SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines

Frontiers in Oncology, 2014
Purpose: To report an update of our previous experience using stereotactic body radiation therapy (SBRT) for the primary treatment of prostate cancer, risk stratified by the updated NCCN version 2.2014, reporting efficacy and toxicity in a community ...
Matthew eBernetich, Matthew eBernetich, Caspian eOliai, Rachelle eLanciano, Rachelle eLanciano, Rachelle eLanciano, Alexandra eHanlon, John eLamond, John eLamond, Stephen eArrigo, Stephen eArrigo, Jun eYang, Jun eYang, Michael eGood, Jing eFeng, Royce eBrown, Bruce eGarber, Michael eMooreville, Luther W. Brady, Luther W. Brady   +19 more
doaj   +1 more source